Tag: Niraparib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Niraparib

Tesaro (NASDAQ:TSRO) Receives Lower Rating From Argus. What's The Reasoning Behind This ...

Added to Collection on: 2018-08-15 03:54:01

Tags for this article:

Money
Finance
Economy
NASDAQ
Short
Tesaro
Niraparib

Click the tags to see associated articles and topics

View Article Details
Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer

Added to Collection on: 2019-01-03 20:00:00

Tags for this article:

Medicine
Boston
Biology
Cellular processes
Senescence
Cancer
Antineoplastic drugs
Lactams
Niraparib
PARP inhibitors
Olaparib
PARP1
PARP2

Click the tags to see associated articles and topics

View Article Details
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using ...

Added to Collection on: 2021-01-18 05:15:00

Tags for this article:

Orphan drugs
PARP inhibitors
Medicine
Health
Niraparib
Piperidines
Progression-free survival
Ovarian cancer

Click the tags to see associated articles and topics

View Article Details
Global Ovarian Cancer Drug Market Industry Outlook 2021-2026||F. Hoffmann-La Roche Ltd, Pfizer ...

Added to Collection on: 2021-01-25 16:42:51

Tags for this article:

Drugs
Health
Clinical medicine
Orphan drugs
PARP inhibitors
Oncology
Lactams
Cancer treatments
Rucaparib
Bevacizumab
Ovarian cancer
Niraparib

Click the tags to see associated articles and topics

View Article Details
SMC endorses Alexion's Ultomiris

Added to Collection on: 2021-05-11 09:00:00

Tags for this article:

Clinical medicine
Medicine
Health
Orphan drugs
Blood disorders
Syndromes
Lymphoma
Atypical hemolytic uremic syndrome
Eculizumab
Niraparib
Hemolytic–uremic syndrome
Mycosis fungoides
Alexion

Click the tags to see associated articles and topics

View Article Details
Scotland backs NHS use of Alexion's Ultomiris for rare disease aHUS

Added to Collection on: 2021-05-11 08:15:00

Tags for this article:

Health
Clinical medicine
Orphan drugs
Blood disorders
Rare diseases
Syndromes
Atypical hemolytic uremic syndrome
Eculizumab
Healthcare Improvement Scotland
Hemolytic–uremic syndrome
Niraparib
National Health Service
Soliris

Click the tags to see associated articles and topics

View Article Details
Pharmalittle: AstraZeneca sues Glaxo over a big-selling cancer drug; EU offers rival plan to Covid ...

Added to Collection on: 2021-06-07 13:18:45

Tags for this article:

Companies
Life Sciences
Health care
GlaxoSmithKline
Tesaro
AstraZeneca
AZN
STAT
Niraparib

Click the tags to see associated articles and topics

View Article Details
Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay

Added to Collection on: 2021-09-07 13:30:00

Tags for this article:

Life Sciences
Health care
Health sciences
Orphan drugs
PARP inhibitors
Lactams
Olaparib
Phthalazines
Illumina Inc.
BRCA1
Niraparib
Molecular diagnostics
Illumina

Click the tags to see associated articles and topics

View Article Details
Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032

Added to Collection on: 2022-06-20 16:18:51

Tags for this article:

Life Sciences
Companies
Anatomy
Prostate cancer
Histopathology
Endocyte
Sanofi
Management of prostate cancer
Bristol-Myers Squibb
Prostate
Lutetium (177Lu) vipivotide tetraxetan
Exelixis
Nivolumab
France
Japan
United Kingdom
Firmagon
Germany
Italy
Cabozantinib
DelveInsight Business Research LLP
United States
Niraparib
Spain

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Lynparza to dominate PARP inhibitors market with $4 billion in sales by 2027 ...

Added to Collection on: 2024-04-24 13:11:58

Tags for this article:

PARP inhibitors
Orphan drugs
Fluoroarenes
Lactams
Olaparib
Cancer treatment
PARP1
Breast cancer
Niraparib
AstraZeneca
Prostate cancer
Targeted therapy

Click the tags to see associated articles and topics

View Article Details